Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Trileptal (oxcarbazepine) Treatment Report
What is Trileptal?

Trileptal is a brand name for the drug oxcarbazepine. It is an anticonvulsant used to treat certain types of seizures in people who have epilepsy. It works by decreasing abnormal excitement in the brain.

Side Effects

Side effects as an overall problem

Severe
1 11%
Moderate
3 33%
Mild
1 11%
None
4 44%

Most commonly reported side effects

dry mouth
3 33%
Excessive daytime sleepiness (somnolence)
3 33%
skin reaction in sunlight
1 11%
Unsteady gait
1 11%
upset stomach
1 11%
Weight gain
1 11%
  • Mild
  • Moderate
  • Severe

Dosages

  150mg as needed daily 150 mg daily 300 mg daily 450 mg daily 600 mg daily 900 mg daily 1200 mg daily 1800 mg daily
  1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 6 Number of Patients: 6 3 Number of Patients: 3 14 Number of Patients: 14 3 Number of Patients: 3 6 Number of Patients: 6 4 Number of Patients: 4  

Stop Reasons

Why Patients Stopped Taking Trileptal (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other
4 44% Other: 44%
Side effects too severe
3 33% Side effects too severe: 33%
Course of treatment ended
2 22% Course of treatment ended: 22%
Doctor's advice
1 11% Doctor's advice: 11%

See all 8 patients who’ve stopped taking Trileptal

Currently Taking Trileptal

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
2
6
5
7

Stopped Taking Trileptal

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
3
1
2
1

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
7 78%
Usually
1 11%
Sometimes
1 11%
Never
0 0%

Burden

Difficulty being on treatment

Very
1 11%
Somewhat
2 22%
A little
0 0%
Not at all
6 67%

Cost

Paid out of pocket

$200+
0 0%
$100-199
1 11%
$50-99
0 0%
$25-49
1 11%
< $25
5 56%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.